Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Receives $54.50 Consensus Price Target from Brokerages
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Get Free Report) has been given an average rating of “Moderate Buy” by the five brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the […]
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Get Free Report) has been given an average rating of “Moderate Buy” by the five brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the […]
